Target intelligence / Profile preview

ERICH2 divergent transcript (ERICH2-DT)

Target
ERICH2-DT
Molecular classification
Long noncoding RNA (lncRNA), Divergent transcript, Other
01

Overview

The ERICH2 divergent transcript (ERICH2-DT) is a long noncoding RNA (lncRNA) gene classified as a divergent transcript, meaning it is transcribed from the opposite DNA strand in close proximity to a protein-coding gene (in this case, ERICH2)[7]. Divergent lncRNAs are known to potentially regulate the expression of neighboring protein-coding genes through various mechanisms, including chromatin remodeling and cis-regulation. There is limited evidence to suggest that ERICH2-DT has been characterized as a direct therapeutic target, nor are there any known drugs or disease associations specifically documented for this RNA[4][7].\n\nKey clarifications:\n- ERICH2-DT is not a protein, receptor, transporter, channel, enzyme, nor a classic therapeutic target.\n- The available evidence highlights its classification as a noncoding RNA gene, with possible regulatory functions inferred from broader lncRNA biology[2][3][4][7].\n- The search results indicate limited functional or clinical annotation specifically for ERICH2-DT.\n\nIf you need structured information for classic drug targets, ERICH2-DT does not fit this category at present.

Other names
ERICH2-DTERICH2 divergent transcript
02

Biological functions

Potential regulation of adjacent protein-coding gene transcription (by analogy to other divergent lncRNAs)Other

Beyond the preview

Go deeper on ERICH2 divergent transcript (ERICH2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ERICH2 divergent transcript (ERICH2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call